Suneetha Vuppu

Prof. Suneetha Vuppu

BIOTECHNOLOGY, Vellore Institute of Technology, Vellore, Tamil Nadu, India., Vellore, India
orcid
Suneetha Vuppu

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of Environmental Chemical Engineering
Verified
Journal Article
Closed access
CPCheera Prasad
Cheera Prasad
PMP. Krishna Murthy
P. Krishna Murthy
RKR. Hari Krishna
R. Hari Krishna
RRR. Sreenivasa Rao
R. Sreenivasa Rao
Suneetha VuppuSuneetha Vuppu
Suneetha Vuppu
PVPonneri Venkateswarlu
Ponneri Venkateswarlu

10 October 2022 in Pharmacological Reports
Verified
Journal Article
Closed access
PDF file
Vivek P. ChavdaVivek P. Chavda
Vivek P. Chavda
Suneetha VuppuSuneetha Vuppu
Suneetha Vuppu
TMToshika Mishra
Toshika Mishra
SKSathvika Kamaraj
Sathvika Kamaraj
APAayushi B. Patel
Aayushi B. Patel
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen

1 January 2014 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Closed access
PSPrithwijit Sarkar
Prithwijit Sarkar
SBShreya Bhagavatula
Shreya Bhagavatula
Suneetha VuppuSuneetha Vuppu
Suneetha Vuppu

30 October 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HSHitakshika Suri
Hitakshika Suri
HSHarshika Suri
Harshika Suri
NNNachiket Nagda
Nachiket Nagda
TMToshika Misra
Toshika Misra
Suneetha VuppuSuneetha Vuppu
Suneetha Vuppu
Human skin is inhabited by commensal microbiota comprising bacteria, fungi, viruses, and demodex mites. The skin microbiome is associated with several vital functions for the host, such as maintaining barrier integrity, modulating lipid homeostasis, eliminating pathogens, and stimulating the immune reactions. However, alterations in the composition of the skin microbiome are often found to be linked with inflammatory dermatological conditions like atopic dermatitis, psoriasis, acne vulgaris, rosacea, and wound-associated infections. These conditions can be diagnosed using culture-dependent and advanced culture-independent analyses, including multi-omics platforms and high-throughput sequencing technologies. Developments in microbiome research and biotechnology have catalysed initiatives to modify the skin microbiota as a therapeutic intervention. Current strategies encompass precision medicine utilising biomarkers, transplantation of complete microbial consortia, application of specific commensal microbes, bacteriophage therapy, use of pre- and probiotic metabolites, as well as sanitizers and antibiotics. This study consolidates existing knowledge regarding the composition and functional roles of the skin microbiome, investigates dysbiosis in skin pathologies, and examines potential microbiome-targeted therapeutic interventions. The study intends to address the challenges and future directions related to the clinical implementation of microbiome-targeted approaches, encompassing the regulatory aspects necessary to guarantee the efficacy and safety of innovative diagnostic and therapeutic applications.

1 December 2020 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
PGPraveen Kumar Govindaraji
Praveen Kumar Govindaraji
Suneetha VuppuSuneetha Vuppu
Suneetha Vuppu
Pectinases are enzymes which are widely distributed in microbes that are present in pectin enriched sites. The agro-industrial residues can be utilized in the industrial scale for low-cost and efficient pectinase production in an eco-friendly approach. This study employs low-cost substrates (i.e. culinary fruit peels) for maximum pectinase production from novel Streptomyces fumigatiscleroticus VIT-SP4. The extraction and characterization of pectin from different fruit peels were investigated and pectinase activity was analyzed. The orange pectin gave maximum pectinase activity of about 45.93 (U/mL). Further, statistical optimization of process parameters was studied by using Taguchi method showed optimum values of pH-6, temperature −35 °C, orange pectin% − 2.5, incubation time- 48 h and RPM- 200 rpm and pectinase activity was found to be 98.65 (U/mL). The response surface methodology (RSM) was used for the optimization of media components which revealed that starch −1.17%, yeast extract-2%, and orange pectin% − 0.75% produces maximum pectinase of about 170.05 (U/mL). The drug-delivery study showed drug release was not observed at initial pH 3 after 4 h. The immediate drug release was noted at pH 6 caused due to disintegration of pectin by the pectinase activity. The self-healing of cracks by spray culture technique was investigated. The crack healing was observed up to 0.50 mm wide after 12 days. This confirms the ability of actinomycete spores to survive and they react to form calcite complex directly helps in crack healing process. This low-cost microbial pectinase can be used in drug delivery and concrete crack-healing applications sectors in future.

19 February 2024 in Expert Review of Vaccines
Verified
Journal Article
Open access
Vivek P. ChavdaVivek P. Chavda
Vivek P. Chavda
Suneetha VuppuSuneetha Vuppu
Suneetha Vuppu
TMToshika Mishra
Toshika Mishra
SKSathvika Kamaraj
Sathvika Kamaraj
NSNikita Sharma
Nikita Sharma
Vasso ApostolopoulosVasso Apostolopoulos
Vasso Apostolopoulos
The escalating prevalence of infectious diseases is an important cause of concern in society. Particularly in several developing countries, infectious diarrhea poses a major problem, with a high fatality rate, especially among young children. The condition is divided into four classes, namely, acute diarrhea, invasive diarrhea, acute bloody diarrhea, and chronic diarrhea. Various pathogenic agents, such as bacteria, viruses, protozoans, and helminths, contribute to the onset of this condition. The review discusses the scenario of infectious diarrhea, the prevalent types, as well as approaches to management including preventive, therapeutic, and vaccination strategies. The vaccination techniques are extensively discussed including the available vaccines, their advantages as well as limitations. There are several approaches available to develop new-improved vaccines. In addition, route of immunization is important and aerosols/nasal sprays, oral route, skin patches, powders, and liquid jets to minimize needles can be used. Plant-based vaccines, such as rice, might save packing and refrigeration costs by being long-lasting, non-refrigerable, and immunogenic. Future research should utilize predetermined PCR testing intervals and symptom monitoring to identify persistent pathogens after therapy and symptom remission.